Fact CheckerSign in

NCT07268378Enrolling by invitation

Supervision of Clinicians in Oncology by Psycho-oncologists : Evaluation

Efficacy of Supervision of Oncology/Haematology Clinicians by Psycho-oncologists: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 16 Dec 2025

Brief summary (registry, in English)

Communication in the oncology setting involves cognitive as well as emotional challenges for both clinicians and patients, and interactional dimensions that emerge in their encounter. Supervision of oncology/haematology clinicians by psycho-oncologists is one of the most frequently used tools, which aims to enhance their communicative and relational competences, and at the same time to support them in their daily clinical work. However, little is known regarding its impact and how the supervisory process acts upon clinicians. This study thus aims to evaluate the efficacy of four 1-hour supervision sessions following a clinician-centred format, which allows supervisors to rapidly access supervisees' own difficulties in the encounter with certain patients. In addition, the supervisory process will be examined qualitatively by analysing in-depth audio-taped supervision sessions. The focus of analysis will be "what works" and "what does not". If beneficial effects are found, clinician-centred supervision -- thanks to its focused and time saving format -- could be realistically implemented for nurses and physicians working in the oncology and haematology settings. Effects are expected on clinicians' capacity to reflect on challenging encounters with patients, on potential negative feelings towards patients, and on clinicians' professional well-being. The clinician-centred supervision format could be easily taught to psycho-oncologists who wish to start supervising haematology and oncology clinicians. Clinicians who are less preoccupied with themselves, or with negative feelings towards their patients, have more supportive relationships with them, which is of utmost importance in critical settings such as oncology and haematology.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
62 (estimated)
First submitted
2 Sept 2025
Start date
11 Aug 2025
Primary completion date
30 Apr 2026
Lead sponsor
Centre Hospitalier Universitaire Vaudois
NCT number
NCT07268378

What you commit to

  • Study type: Interventional
  • Planned participants: 62
  • From 11 Aug 2025 to the primary completion date, 30 Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Participation to individual supervision by psycho-oncologists as part of the following training courses: CAS in psycho-oncology and course "Mieux Commu iquer"
  • Participated in a study involving supervision by psycho-oncologists

Who the study is looking for

  • Physician or nurse in oncology or hematology
  • Specialized in medical oncology or hematology

Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Psychiatrie de liaison
Coordinator of this site? Confirm its status
LausanneSwitzerlandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.